| Screening and enrollment | Prior to RT | During radiation therapy (RT)a | Post-RT | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Baseline | CT simulation visit | Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | Week 6 | Week 7 | Week 12 | |
Enrollment | ||||||||||
 Consent | X |  |  |  |  |  |  |  |  |  |
 Eligibilityb | X |  |  |  |  |  |  |  |  |  |
 Randomizationc | X |  |  |  |  |  |  |  |  |  |
Intervention | ||||||||||
 CT simulation |  | X |  |  |  |  |  |  |  |  |
 In-person or virtual GI session |  | X | X |  |  |  |  |  |  |  |
Assessment | ||||||||||
 Demographics | X |  |  |  |  |  |  |  |  |  |
 Patient self-administered GI used |  |  | X | X | X | X | X | X | X |  |
 Anxiety HADS-A | X |  | X |  | X |  |  |  | X | X |
 Depression HADS-D | X |  | X |  | X |  |  |  | X | X |
 Symptoms MSAS-SF | X |  |  |  | X |  |  |  | X | X |
 Health-related QOL FACT-HN | X |  |  |  | X |  |  |  | X | X |
 Intervention use TLFB-Id |  | X | X | X | X | X | X | X | X |  |
 Anxiolytic use TLFB-A |  | X | X | X | X | X | X | X | X |  |
Qualitative interview | ||||||||||
 Research assistant contact for F/Ue |  |  |  |  |  |  |  |  |  | X |
 Qualitative interviewf |  |  |  |  |  |  |  |  |  | X |